All chemical reagents for the synthesis were obtained from Sigma Aldrich, Alfa Aesar, or MERCK, and used without further purification unless otherwise specified. Column chromatography was carried out on Merck Silica Gel 60 (0.040-0.064 mm, 230−400 mesh).
Values are represented as means and error bars as standard deviations (n = 3). The intensity of sample from health care products is 5686± 297.6. Figure S12 . L-DOPA concentration in DOPA Mucuna Veg Capsules. Y axis is L-DOPA peak area appeared on HPLC at 254 nm. The intensity of sample from health care products is 5686± 297.6. Sample preparation: 9.9 mg sample was dissolved in 7.5 mL DI water (stock sample solution), strenuous vibration for 5 min, then filter to remove insoluble substances.
HPLC Method: 50 µL stock sample solution was injected to HPLC for L-DOPA peak area calculation.
Synthesis and Characterization
Preparation of Resa-Sulf. To a stirred solution of Resazurin (200 mg, 0.87 mmol) and potassium carbonate (400 mg, 2.89 mmol) in 10 mL dimethylformamide (DMF), 1,4-Butane sultone (1 mL, 9.77 mmol) was added under argon atmosphere. The mixture was stirred at 60 ºC for overnight. The reaction was monitored by LC-MS and a red product with reduced polarity was observed. After cooling to room temperature, the DMF reaction solution was dropped into ethyl acetate and let the solution stand for 5 min. Then the precipitate was filtered and washed with ethyl acetate and dichloromethane for 3 times respectively. Later, the precipitate was collected and purified by preparative TLC with a solvent system (acetonitrile : water = 100 : 15) and brown solid products were obtained. 12, 164.66, 154.21, 149.24, 131.28, 130.32, 124.28, 123.36, 121.34, 115.68, 104.20, 100.78, 69.14, 50.55, 26.99, 20.80 . was stirred at 60 ºC for 6 h. The reaction was monitored by LC-MS and a red product with reduced polarity was observed. After cooling to room temperature, 50 mL DCM was added and the mixture was extracted with water (3 x 100 mL). The organic phase was collected and removed under vacuum condition. Then the mixture was purified by preparative TLC with a solvent system (DCM : MeOH = 100 : 5) and red solid Resa-Br was obtained. The product was used in the next step directly. Resa-Br (100 mg, 0.28 mmol), potassium carbonate (200 mg, 1.44 mmol) and phenol (131.6 mg, 1.4 mmol) were added into 5 mL dimethylformamide (DMF). The mixture was stirred at 60 ºC for 6 h. The reaction was monitored by LC-MS and a red product with reduced polarity was observed. After cooling to room temperature, 20 mL DCM was added and the mixture was extracted with water (3 x 50 mL). The organic phase was collected and removed under vacuum condition. Then the mixture was purified by preparative TLC with a solvent system (DCM : MeOH = 100 : 5) and red solid Resa-Con was obtained. 98, 163.86, 158.64, 152.98, 149.04, 132.66, 130.87, 129.68, 124.51, 122.92, 122.00, 121.13, 114.48, 114.17, 105.70, 101.06, 65.96, 63.64, 29.05 HRMS m/z (C21H17NO5), calculated 364.1185, found: 364.1172 
Resa

Preparation of Reso-Sulf. Resa-Sulf (10 mg, 0.027 mmol) and L-DOPA (10.8 mg, 0.04 mmol) were dissolved in 5 mL PBS buffer (pH 11.2). After stirring for 60 min at 25 ºC, the solution was removed under vacuum. The product was purified by preparative TLC with a solvent system (acetonitrile : water = 100 : 15) Yield: 8.48 mg (90.5%). 1 H NMR (600 MHz, D2O) δ 7.45 (d, J = 9.0 Hz, 1H), 7.30 (d, J = 9.7 Hz, 1H), 6.87 (dd, J = 9.0, 2.6 Hz, 1H), 6.76 (d, J = 2.5 Hz, 1H), 6.73 (dd, J = 9.7, 2.1 Hz, 1H), 6.15 (d, J = 2.1 Hz, 1H), 4.02 (t, J = 5.5 Hz, 2H), 2.96 -2.90 (m, 2H), 1.92 -1.81 (m, 4H). 13 C NMR (151 MHz, D2O) δ 187. 93, 164.01, 150.78, 145.84, 143.21, 134.53, 132.88, 130.97, 127.75, 115.45, 105.46, 100.60, 68.89, 50.58, 27.06, 20.82. HRMS m/z (C16H14NO6S -), calculated: 348.0541, found: 348.0547, [M -].
